Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy
Saved in:
| Main Authors: | Suravi Raychaudhuri, Megan Othus, Mary-Elizabeth M. Percival, Guillermo Garcia-Manero, Frederick R. Appelbaum, Harry P. Erba, Jacob S. Appelbaum |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Graft-<i>versus</i>-leukemia
by: Frederick R. Appelbaum
Published: (2025-06-01) -
Clinical Features and T‐Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC‐TFR Study
by: Hiroshi Ureshino, et al.
Published: (2025-08-01) -
Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01) -
Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril
by: I. L. Davydkin, et al.
Published: (2020-03-01) -
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies
by: David Kegyes, et al.
Published: (2025-08-01)